title: Is it time to revisit orphan drug policies?
authors.forename: Christopher
authors.initials: C
authors.lastname: McCabe
authors.forename: Tania
authors.initials: T
authors.lastname: Stafinski
authors.forename: Devidas
authors.initials: D
authors.lastname: Menon
mesh_terms: D006291:Health Policy; D006801:Humans; D009965:Orphan Drug Production; D035583:Rare Diseases / Q000188:drug therapy*